Test Directory
| Test Code | ||||
| DB1AB | ||||
| Test Name | ||||
| Diabetes Type 1 Autoantibody Panel | ||||
| CPT Codes | ||||
| 86337, 86341 X 3 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 6 - 7 days | ||||
| Clinical Utility | ||||
|
The American Diabetes Association supports using autoantibody (AAb) screening to diagnose T1D. T1D autoantibodies are markers of ongoing damage to insulin-producing beta cells. The four AAbs used in clinical practice to diagnose T1D are: AAbs against insulin (IAA), tyrosine phosphatase IA2 (IA2A), glutamic acid decarboxylase (GAD65), and zinc transporter. Numerous clinical trials demonstrate important clinical benefits associated with detecting T1D using an AAb screening approach. Clinical guidelines have been established to help identify T1D at its earliest phases and before progression to DKA, providing presymptomatic and symptomatic staging of T1D. |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain
Desired Specimen Volume: 4 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory frozen |
||||
| Stability Requirements | ||||
|
||||
| Causes for Rejection | ||||
|
||||
| Methodology | ||||
| Varies By Test | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| Quest Diagnostics Nichols Institute | ||||
| Testing Schedule | ||||
| Routine, 2 times per week | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.